Literature DB >> 21936017

Pharmacovigilance systems and databases in Korea, Japan, and Taiwan.

Tomomi Kimura1, Yasuyuki Matsushita, Yea-Huei Kao Yang, Nam-Kyong Choi, Byung-Joo Park.   

Abstract

PURPOSE: The aim of this article is to qualitatively describe the characteristics of spontaneous reporting systems, signal detection methods, and observational databases in Korea, Japan, and Taiwan.
METHODS: National statistics and published literature were reviewed to determine the annual number of spontaneous reports and the main source (reporters) for each country. The data items collected for spontaneous reports, mode of transmission, availability of reports, and quantitative methods for signal detection were compared across the countries. The characteristics of the national insurance claims databases also were summarized.
RESULTS: The number of annual domestic spontaneous reports in 2007 from Korea, Japan, and Taiwan were 3751, 32,391, and 6971, respectively, which increased to 26,827, 34,649, and 10,320, respectively, over the next 2 years. If adjusted by total population, the latter would be 5.59, 2.71, and 4.49 per 10,000 persons, respectively. The reports were directly submitted mainly by physicians (51%) in Korea and hospital pharmacists (65%) in Taiwan, whereas 89% of the reports in Japan were submitted by manufacturers. Routine data mining of the national spontaneous report database has been implemented in Japan and will be in Korea and Taiwan.
CONCLUSIONS: Differences in quantity and submission practice of spontaneous reports should be noted for potential comparison among these countries/regions, as well as with those from Western countries, even after the full implementation of national data mining system. Nationwide claims databases with nearly 100% coverage are great assets for pharmacovigilance and pharmacoepidemiology and can be major contributors to global pharmacovigilance.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21936017     DOI: 10.1002/pds.2244

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  11 in total

1.  Adverse events attributed to traditional Korean medical practices: 1999-2010.

Authors:  Hyeun-Kyoo Shin; Soo-Jin Jeong; Myeong Soo Lee; Edzard Ernst
Journal:  Bull World Health Organ       Date:  2013-05-31       Impact factor: 9.408

Review 2.  Postmarketing safety surveillance : where does signal detection using electronic healthcare records fit into the big picture?

Authors:  Preciosa M Coloma; Gianluca Trifirò; Vaishali Patadia; Miriam Sturkenboom
Journal:  Drug Saf       Date:  2013-03       Impact factor: 5.606

Review 3.  Pharmacists in pharmacovigilance: can increased diagnostic opportunity in community settings translate to better vigilance?

Authors:  Paul Rutter; David Brown; Justine Howard; Christine Randall
Journal:  Drug Saf       Date:  2014-07       Impact factor: 5.606

Review 4.  Adverse drug event reporting systems: a systematic review.

Authors:  Chantelle Bailey; David Peddie; Maeve E Wickham; Katherin Badke; Serena S Small; Mary M Doyle-Waters; Ellen Balka; Corinne M Hohl
Journal:  Br J Clin Pharmacol       Date:  2016-05-09       Impact factor: 4.335

Review 5.  Integrative approaches for predicting in vivo effects of chemicals from their structural descriptors and the results of short-term biological assays.

Authors:  Yen Sia Low; Alexander Yeugenyevich Sedykh; Ivan Rusyn; Alexander Tropsha
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

6.  The intriguing future of pharmacoepidemiology.

Authors:  Björn Wettermark
Journal:  Eur J Clin Pharmacol       Date:  2013-05-03       Impact factor: 2.953

7.  Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis.

Authors:  Francesca Scicchitano; Chiara Giofrè; Caterina Palleria; Carmela Mazzitello; Miriam Ciriaco; Luca Gallelli; Laura Paletta; Giuseppina Marrazzo; Salvatore De Fazio; Michele Menniti; Rubens Curia; Concetta Arena; Serafina Chimirri; Marinella Patanè; Stefania Esposito; Felisa Cilurzo; Orietta Staltari; Emilio Russo; Giovambattista De Sarro
Journal:  J Res Med Sci       Date:  2012-09       Impact factor: 1.852

8.  Bias in spontaneous reporting of adverse drug reactions in Japan.

Authors:  Shinichi Matsuda; Kotonari Aoki; Takuya Kawamata; Tetsuji Kimotsuki; Takumi Kobayashi; Hiroshi Kuriki; Terumi Nakayama; Seigo Okugawa; Yoshihiko Sugimura; Minami Tomita; Yoichiro Takahashi
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

9.  Effect of database profile variation on drug safety assessment: an analysis of spontaneous adverse event reports of Japanese cases.

Authors:  Kaori Nomura; Kunihiko Takahashi; Yasushi Hinomura; Genta Kawaguchi; Yasuyuki Matsushita; Hiroko Marui; Tatsuhiko Anzai; Masayuki Hashiguchi; Mayumi Mochizuki
Journal:  Drug Des Devel Ther       Date:  2015-06-12       Impact factor: 4.162

10.  Assessment of statin-associated muscle toxicity in Japan: a cohort study conducted using claims database and laboratory information.

Authors:  Chia-Hsien Chang; Makiko Kusama; Shunsuke Ono; Yuichi Sugiyama; Takao Orii; Manabu Akazawa
Journal:  BMJ Open       Date:  2013-04-11       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.